Dr. Nandagopal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4501 Empire Ct
Fredericksburg, VA 22408Phone+1 540-371-0079Fax+1 540-656-2653
Education & Training
- University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
- University of Alabama at BirminghamCertificate, Clinical and Translational Science, 2017
- University of Alabama at BirminghamCertificate, Clinical Investigator Training Program, 2017
- Wayne State University School of MedicineResidency, Internal Medicine, 2010 - 2013
- OtherClass of 2008
Certifications & Licensure
- VA State Medical License 2022 - 2026
- AL State Medical License 2015 - 2022
- MI State Medical License 2010 - 2016
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 39 citationsCirculating tumor DNA alterations in patients with metastatic castration‐resistant prostate cancerGuru Sonpavde, Neeraj Agarwal, Gregory R. Pond, Rebecca J. Nagy, Roberto Nussenzveig
Cancer. 2019-05-01 - 307 citationsKidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.Robert J Motzer, Eric Jonasch, Neeraj Agarwal, Ajjai Alva, Michael Baine
Journal of the National Comprehensive Cancer Network. 2022-01-01 - 53 citationsObesity diminishes response to PD-1-based immunotherapies in renal cancer.Shannon K. Boi, Rachael M. Orlandella, Justin T. Gibson, William J. Turbitt, Gal Wald
Journal for Immunotherapy of Cancer. 2020-12-01
Journal Articles
- Overview of Current and Future Adjuvant Therapy for High-Risk Localized Renal Cell CarcinomaNandagopal L, Naik G, Sonpavde G, Current treatment options in Oncology, 1/18/2018
- Timing of androgen deprivation therapy in prostate cancerNandagopal L, Lancet Oncology, 1/1/2017
- Treatment approaches of hard-to-treat non-Hodgkin lymphomasNandagopal L, Mehta AK, Expert Review of Hematology, 1/1/2016
- Join now to see all
Abstracts/Posters
- Improving hepatitis B screening prior to Rituximab-based treatments at a multi-specialty urban VA hospitalNandagopal L, Paluri R, Gleaton B, Nabell L, ASCO Quality Care Symposium, Orlando, FL, 1/1/2017
- Factors affecting outcomes in gall bladder cancer � a single institution retrospective analysisNandagopal L, Heslin M, Porterfield J R, Javob R, Li P, Posey J, Paluri R, AACR annual meeting, 1/1/2017
- The diagnostic and therapeutic challenges in an unusual case of Stills disease and Systemic lupus erythematosus overlap - A Spectrum of Auto-inflammatory Syndrome?Nandagopal L, Itikyala S, Neill D, Nagori K,Ramchandren R, Krishnamurthy V, Sagar H, York R, Venkatram M, ACP Associates Day, MI, 1/1/2014
- Join now to see all
Lectures
- Urothelial carcinomaUniversity of Alabama at Birmingham, Birmingham, AL - 1/1/2018
- Molecular advances in prostate cancerUniversity of Alabama at Birmingham, Birmingham, AL - 1/1/2018
- Prostate cancer 101- a primer for Fellows1/1/2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: